Alex Aravanis is the CEO and co-founder of Moonwalk Biosciences, a biotechnology company pioneering precision epigenetic medicines. In this episode, Chris and Alex discuss Moonwalk’s innovative approach to developing a new class of medicines aimed at treating complex diseases and potentially extending human healthspan.
The Finer Details:
- The concept of epigenetics as the “source code” for cell states
- Moonwalk’s technology for analyzing and modifying the epigenome
- The company’s focus on cardiometabolic diseases and adiposity
- Comparison of Moonwalk’s approach to other epigenetic reprogramming strategies
- Potential applications in treating obesity and metabolic disorders
- The use of AI and machine learning in epigenetic research
- Future directions and challenges for Moonwalk Biosciences
Company Website
2 Likes
Its a 42 minute podcast. Is there a transcript anywhere.
No - I could not find any transcripts for the Translating Aging podcasts.
What they are doing (as described in the podcast) is explained visually here:
1 Like
If you use Apple Podcast (the player app) you will see a transcript. I was not able to copy the text however because…that functionality is blocked to serve Apple’s economic interests.
3 Likes
Another company working on rewriting the epigenome:
Company Website:
News on Shift Bioscience
2 Likes
